ScholarRx Revenue and Competitors

Location

N/A

Total Funding

Education

Industry

Estimated Revenue & Valuation

  • ScholarRx's estimated annual revenue is currently $16.9M per year.(i)
  • ScholarRx's estimated revenue per employee is $180,000

Employee Data

  • ScholarRx has 94 Employees.(i)
  • ScholarRx grew their employee count by -14% last year.

ScholarRx's People

NameTitleEmail/Phone
1
VP, Academic SolutionsReveal Email/Phone
2
Director Quality & DeliveryReveal Email/Phone
3
Senior Director Academic SolutionsReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Director, Academic SolutionsReveal Email/Phone
6
Director Basic Science EducationReveal Email/Phone
7
Senior Director CurriculumReveal Email/Phone
8
Director Editorial and Program ManagementReveal Email/Phone
9
Digital Marketing ManagerReveal Email/Phone
10
Project ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$16.9M94-14%N/AN/A
#2
$15.5M866%N/AN/A
#3
N/A6331%N/AN/A
#4
$33.9M17115%N/AN/A
#5
$18.4M10217%N/AN/A
#6
$180.4M716N/AN/AN/A
#7
$244.9M972N/AN/AN/A
#8
$12.2M759%N/AN/A
#9
$88M391N/AN/AN/A
#10
$95.4M4247%N/AN/A
Add Company

What Is ScholarRx?

ScholarRx is a leading provider of accessible, sustainable medical education solutions for medical schools worldwide. Our new Rx Bricks initiative features collections of interlocking foundational-learning “bricks” that empower faculty to rapidly design and develop engaging, evidence-based curricular experiences. Our USMLE-Rx assessment platform combines authentic USMLE-style Q&A, digital flashcards, and high-yield video all powered by First Aid for the USMLE Step 1 with robust performance reporting to create personalized active-learning experiences with measurable outcomes.

keywords:N/A

N/A

Total Funding

94

Number of Employees

$16.9M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$20.7M9411%N/A
#2
$15M958%N/A
#3
$30.9M957%N/A
#4
$27.6M9519%N/A
#5
$3.5M95-23%N/A